Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Health Care Law Today
FDA Continues to Take Stance That it Will Not Issue CBD Rules
The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.